The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of retreatment with oxaliplatin-based regimens in metastatic colorectal cancer patients: The RETROX-CRC retrospective study.
 
Gianluca Mauri
No Relationships to Disclose
 
Alessio Amatu
Honoraria - CheckmAb
Consulting or Advisory Role - Bayer; Roche
 
Federica Tosi
No Relationships to Disclose
 
Katia Bencardino
No Relationships to Disclose
 
Erica Bonazzina
No Relationships to Disclose
 
Viviana Gori
No Relationships to Disclose
 
Lorenzo Ruggieri
No Relationships to Disclose
 
Sabrina Arena
Consulting or Advisory Role - MSD
 
Alberto Bardelli
Stock and Other Ownership Interests - Neophore
Honoraria - Guardant Health; Illumina; Inivata
Consulting or Advisory Role - Inivata; Neophore
Research Funding - AstraZeneca; Boehringer Ingelheim; Neophore
 
Silvia Marsoni
Consulting or Advisory Role - Axiom Healthcare Strategies; Ellipses Pharma
 
Salvatore Siena
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; CheckmAb; Clovis Oncology; Daiichi Sankyo; Incyte; Merck; Novartis; Roche/Genentech; Seagen
Research Funding - MSD Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Andrea Sartore-Bianchi
Consulting or Advisory Role - Amgen; Bayer; Sanofi; SERVIER